Evaluation of Pulmonary Tuberculosis Treatment in Adult Patients at Poly of Pulmonary Diseases Army Hospital Pematangsiantar City
Article Sidebar
Main Article Content
Abstract
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis and is a health problem that still needs serious attention from the government and all levels of society because it can cause death. This study aims to determine the rationale for the treatment of pulmonary tuberculosis in adult patients at the Lung Disease Polyclinic at the Siantar City Army Hospital in 2021 which refers to the National Guidelines for Tuberculosis Management of the Indonesian Ministry of Health and treatment standards from WHO. This research is a non-experimental type with a descriptive evaluative design with retrospective data collection. The study was conducted using the medical records of adult pulmonary tuberculosis patients at the outpatient installation at the Pematang Siantar City Army Hospital in 2021. The results showed that the most common cases of pulmonary tuberculosis in adult patients were male patients, namely 61.22%, the diagnosis was for each patient suspected of pulmonary tuberculosis, a chest X-ray examination and smear test were carried out, pulmonary tuberculosis was treated using two anti-tuberculosis drugs, namely OAT-kombipak and OAT-FDC, 1 case was found with a duration of administration of anti-kombipak anti-tuberculosis drugs that did not comply with standard treatment and patients who received treatment received a score recovery of 97.96% and patients who failed treatment by 2.04%.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Anonymous, 1999, Fixed Dose Combination tablets for the treatment of tuberculosis, http://www.emro.who.int/stb/media/pdf/fdc.pdf. Retrieved April 25, 2007
Anonymous, 2001, National Guidelines for Control of Tuberculosis ,1-45, 6th Printing, Ministry of Health of the Republic of Indonesia, Jakarta
Anonymous, 2002, Indonesia Ranked Third in TB Patients. http:// www.kompas.com/kompas-print/0209/24/Jateng/indo26.htm. Accessed on September 13, 2006 Anonymous, 2003a, Getting to Know TB Better. http://Cyberman.Cbn.Net. Id/definitive.Asp?categories-health-newsno-453.53k. Retrieved 3 November 2006)
Anonymous, 2003b, National Guidelines for Tuberculosis Control, 1-45, 8th Printing, Ministry of Health of the Republic of Indonesia, Jakarta
Anonymous, 2005a, Drug Information, 554-583, American Society of Health, American
Anonymous, 2005b, Tuberculosis, http://www.infection.com/hiv/articles.php?ing=i &pg=57. Retrieved 12 August 2006
Anonymous, 2006, Tuberculosis, http://image.google.co.id/images?svnum =10&hl=id&q=tuberculosis&btnG=Select. Retrieved December 10, 2006
Bahar, Asril., 2003, Internal Medicine, Volume II, 3rd Edition, 819-825, Association of Indonesian Internal Medicine Specialists, FKUI publishing house, Jakarta
Crofton J., Horne MF, 1999. Clinical Tuberculosis, 93-113, Translated by Muherman Harun, 2nd edition, Widya Medika, Jakarta
Isselbacher. K. 1., et al, 1995, Harrison Principles of Internal Medicine, Translated by Ahmad Asdie volume 2, 13th edition, 342-354, EGC Medical Book Publisher, Jakarta
Jawetz, et al, 2001, Medical Microbiology, 147-148, Twenty Second Edition, Medical Publishing Division, New York.
Pandit, Jay & Raj K, Karthi & G., Gokul & Yadav, Abhishek & Arava, Sudheer. (2022). Cardiac Complication of Extrapulmonary Tuberculosis.
Dong, Pham & Cuong, Nguyen & Phuong, Nguyen & Nguyen Hong, Ngoc & Hung, Nguyen & Bùi Sơn, Nhật & Le, Luyen. (2021). Level of Mycobacteria in Pre-Treatment Sputum and Susceptibility of M. tuberculosis Strains Isolated from Patients with non-Multidrug-Resistant Pulmonary Tuberculosis AFB (+) and Factors Influencing MGIT Results after the First 8 Weeks of Anti-Tuberculosi. VNU Journal of Science: Medical and Pharmaceutical Sciences. 37. 10.25073/2588-1132/vnumps.4274.
Medhin, Girmay & Berhe, Gebretsadik & Mulugeta, Afework & Berhe, Nega. (2020). Factors associated with treatment initiation delay among new adult pulmonary tuberculosis patients in Tigray, Northern Ethiopia. PLOS ONE. 15. e0235411. 10.1371/journal.pone.0235411.
Madison, Amanda & Ndeezi, Grace & Chollong, Hassen & Bruno Tongun, Justin & Tumwine, James & Piloya, Thereza. (2021). Pulmonary tuberculosis among young children with severe pneumonia at Al Sabah Children’s Hospital, Juba, South Sudan. South Sudan Medical Journal. 14. 71-79. 10.4314/ssmj.v14i3.2.
Medhin, Girmay & Berhe, Gebretsadik & Mulugeta, Afework & Berhe, Nega. (2020). Delay in treatment initiation and its association with clinical severity and infectiousness among new adult pulmonary tuberculosis patients in Tigray, Northern Ethiopia. 10.21203/rs.3.rs-15737/v2.
Li, Hui & He, Yanfa & Wang, Bin & Song, Xinliang & Zhao, Dawei & Yu, Hang & Qi, Kelei & Liu, Tao. (2021). Rare cases of pulmonary inflammatory myofibroblastic tumors in adult male patients: a case report. Translational Cancer Research. 10. 10.21037/tcr-21-1683.
Irawan, Galuh & Margawati, Ani & Rosidi, Ali. (2017). Underweight increases the risk of pulmonary tuberculosis in adult. Universa Medicina. 36. 4. 10.18051/UnivMed.2017.v36.4-10.
Jaimni, Vijay & Shastry, Barkur & Madhyastha, Sharath & Shetty, Ganesh. V & Acharya, Raviraja & Bekur, Ragini & Doddamani, Akhila. (2021). Association of Vitamin D Deficiency and Newly Diagnosed Pulmonary Tuberculosis. Pulmonary Medicine. 2021. 1-6. 10.1155/2021/5285841.